z-logo
open-access-imgOpen Access
Efficacy ratio: A tool to enhance optimal antimicrobial use for intra-abdominal infections
Author(s) -
Balaji Veeraraghavan,
P. Sabu,
Divyaa Elangovan,
AgilaKumari Pragasam,
YamunaDevi Bakthavatchalam,
Camilla Rodrigues,
DS Chitnis,
BhaskarNarayan Chaudhuri
Publication year - 2018
Publication title -
indian journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.286
H-Index - 59
eISSN - 1998-3751
pISSN - 0253-7613
DOI - 10.4103/ijp.ijp_264_18
Subject(s) - ertapenem , tazobactam , piperacillin , antimicrobial , amikacin , antibiotics , antibiotic resistance , klebsiella pneumoniae , minimum inhibitory concentration , medicine , cefotetan , microbiology and biotechnology , meropenem , biology , escherichia coli , imipenem , bacteria , pseudomonas aeruginosa , gene , biochemistry , genetics
Antimicrobial resistance and inappropriate antibiotic regimen hamper a favorable outcome in intra-abdominal infections. Clinicians rely on the minimum inhibitory concentration (MIC) value to choose from the susceptible antimicrobials. However, the MIC values cannot be directly compared between the different antibiotics because their breakpoints are different. For that reason, efficacy ratio (ER), a ratio of susceptible MIC breakpoint and MIC of isolate, can be used to choose the most appropriate antimicrobial.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom